IQV
IQVIA Holdings Inc.
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Best Diagnostics Stocks 2026 →
IQVIA (IQV) Stock: Buy, Sell, or Hold?
$277.10
+1.95 (+0.71%)
▲
5d:
+5.05%
30d:
+6.3%
90d:
+14.73%
QUANTITATIVE VERDICT
BUY
MODERATE Confidence (59%)
Quality Score
57/100
Position
EXTENDED
30-Day Fair Range
$261.25 – $275.51
Position: EXTENDED
Forward P/E & Valuation
19.4x
STRETCHED
vs 15.3x historical avg
Wall Street Target
$311.89
+13.4% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$252.38 / $282.42
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
💡 BUY OPPORTUNITY: IQV shows positive signals but monitor for confirmation. Market pricing in 8.2% annual growth which appears achievable. Moderate conviction.
Get Alerted When IQV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$301.71
Based on 6.8% avg growth
INTRINSIC VALUE TODAY
$187.34
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 15.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: IQV is currently trading at $277.10, which is considered extended relative to its 30-day fair value range of $261.25 to $275.51. From a valuation perspective, the stock is trading at a premium (Forward PE: 19.4) compared to its historical average (15.3). At these levels, the market is pricing in 8.2% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, IQV is in a strong uptrend. The price is approaching resistance at $282.42. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: IQV scores 63/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $311.89 (+13.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, IQV is in a strong uptrend. The price is approaching resistance at $282.42. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: IQV scores 63/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $311.89 (+13.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$261.25 -
$275.51
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
58.6%
Trading Range & Key Levels
30-Day Trading Range
$261.25 -
$275.51
Current vs Trading Range
EXTENDED
Support Level
$252.38
Resistance Level
$282.42
Current Trend
Strong Uptrend
Technical data as of
Nov 10, 2026
Quantitative Signal Breakdown
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (63/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($311.89)
- NEUTRAL: Trading at premium valuation - market expects 8.2% growth which is achievable
- BULLISH: Bottoming setup score 63/100 — corrected, stabilizing, and turning up
Fundamental Context
Forward P/E (Next Year Est.)
19.37
Wall Street Target
$311.89
(+13.4%)
Revenue Growth (YoY)
8.0%
Earnings Growth (YoY)
8.8%
Profit Margin
8.1%
Valuation Premium vs History
+8.2% premium
PE vs Historical
19.4 vs 15.3
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+8.2%
(market-implied from PE analysis)
1-Year Target
$297.71
(+8%)
2-Year Target
$322.12
(+17%)
3-Year Target
$348.54
(+27%)
3-Yr Target (if PE normalizes)
(PE: 19→15)
PE COMPRESSION
$275.29
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 9.6%)
$371.51
(+35%)
Base:
(SPY PE: 19.4, Growth: 9.6%)
$362.37
(+32%)
Bear:
(PE: 15.3, Growth: 9.6%)
$286.21
(+4%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (34x PE), but valuation improves significantly next year (19x PE) as earnings recover.
Trailing PE: 33.92 | Current EPS (TTM): $8.22
Bull Case
$530.01
(+93%)
Analyst growth 72.8%, PE expands to 37.3
Base Case
$481.83
(+75%)
Market implied 72.8%, PE stable at 33.9
Bear Case
$189.61
(-31%)
Severe decline -20.0%, PE contracts to 28.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share IQV Analysis
Share this live IQV analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (IQV)
Bullish
4 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
3 msgs
24h retail stream
Last Tracked
Oct 27, 2026
Daily AI digest
AI Retail Discussion Summary:
IQVIA reported stronger-than-expected earnings and revenue for the latest quarter according to analysts on StockTwits.
Key Retail Themes:
earnings surprise
revenue beat
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 2:09 PM ET
Data refreshes hourly during market hours. Next update: 3:09 PM
Data refreshes hourly during market hours. Next update: 3:09 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IQV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
GH
Guardant Health Inc |
STRONG BUY
26 analysts |
$201 | 51 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
23 analysts |
$416 | 65 BUY |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
27 analysts |
$752 | 47 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
24 analysts |
$260 | 51 HOLD |
Advanced IQV Option Strategies
Professional options setups generated by AI based on today's IQV price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive IQV Research Pages
